I want to share three themes that struck me from the Dohmen Life Science Services Entrepreneur Summit in Milwaukee this week. Is there an age or stage of company that doesn’t require innovation? Dohmen started as an apothecary in 1858 and is a private fifth generation company, which has reinvented itself over the last few years.
There were a few long reads that I’ll be re-reading over the weekend, including: New blood (at Fortune, by Roger Parloff @rparloff) This article profiles the blood diagnostics company, Theranos, and the founder, Elizabeth Holmes. While you will find the founder description interesting, I found myself drawn to the questions of business model, trade secrets and regulation.
Tri 4 Schools is a non-profit organization that uses athletic events as a platform to get kids active and fight childhood obesity. I am helping raise $500 for Madison-based Tri 4 Schools by the end of 2013 to pay for shuttle transportation for kids that otherwise couldn’t get to a Tri 4 Schools event. I
Very important note: The tech entrepreneurial community has been talking about depression and entrepreneurship. I’ve included links to some very personal and moving reads at the bottom of this post. The post I’ve written below is not meant to be about depression per se but about the dark spots along the entrepreneurial journey. Into every
In the early years of my entrepreneurship adventure, I would have conversations that would go something like this: Colleague: That is so great that you get total control over your company. You can work on whatever projects you want, choose who you want to work with. Me: Yeah, it fits nicely with my slightly* Type
Bruce Booth, a partner at Atlas Venture wrote a post called Unleashing Biotech Innovation With The Currency of Entrepreneurship. He makes a case that emerging translational R&D models that center on academia are likely to fail because they do not include equity ownership. Since reading the post, I’ve been pondering the question: Is equity ownership